Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis-Reference-Cited by-同舟云学术

Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis

Published:2021-10 Issue: Volume:30 Page:100386
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Wang Yu,Herroon Mackenzie K.,Zielske Steven P.,Ellis Leigh,Podgorski Izabela,Taichman Russell S.,Cackowski Frank C.

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. SEER Cancer Statistics Factsheets: Prostate Cancer. National Cancer Institute. Bethesda, MD. December 9, 2016]; Available from: https://seer.cancer.gov/statfacts/html/prost.html.

2. Mouse models of prostate cancer: picking the best model for the question;Grabowska;Cancer Metastasis Rev.,2014

3. The TRAMP mouse as a model for prostate cancer;Hurwitz;Curr. Protoc. Immunol.,2001

4. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches;Kido;Life Sci.,2019

5. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis;Ma;Cancer Res.,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells;Oncology Reports;2024-01-08

2. Tertiary Lymphoid Structures Validated as Biomarker;Cancer Discovery;2023-11-22

3. AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer;Cancer Discovery;2023-10-20